Verition Fund Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Verition Fund Management's LLY Position: Q2 2026 in Review
Verition Fund Management increased its Eli Lilly (LLY) stake by 12% in Q2 2026, buying an estimated $365K and bringing the position to 3,365 shares worth $4.04M. The position accounts for 0.02% of the portfolio, ranked #751.
Verition Fund Management first reported a position in LLY in Q2 2013 and has held it in 42 quarters since. The position peaked at $182M in Q3 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Verition Fund Management held 3,365 shares of Eli Lilly worth $4.04M as of Q2 2026.
- Verition Fund Management bought 357 Eli Lilly shares in Q2 2026, an estimated $365K.
- Eli Lilly made up 0.02% of Verition Fund Management's portfolio in Q2 2026, its #751 holding.
- Verition Fund Management first reported a position in Eli Lilly in Q2 2013 and has held it in 42 quarters since.
- Verition Fund Management's Eli Lilly position peaked at $182M in Q3 2025.
- 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.